5′-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 4, 2014, Pages 307-314

  Lee, Christopher T ^a   Ussher, John R ^b   Mohammad, Askar ^a   Lam, Anna ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

2 deoxyglucose; AMPK; Cardiac myocyte; Glucose uptake; GLUT4; Glycolysis; Metabolism

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; INSULIN; PHENFORMIN; PROTEIN KINASE B; SERINE; THREONINE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

ANIMAL CELL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL LINE; DRUG EFFECT; METABOLISM; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; ENZYME ACTIVATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; INSULIN; MYOBLASTS, CARDIAC; PHENFORMIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

EID: 84898727966     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0107     Document Type: Article

References (50)

1. Alkhateeb, H., Chabowski, A., Glatz, J.F., Gurd, B., Luiken, J.J., and Bonen, A. 2009. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids. Am. J. Physiol. Endocrinol. Metab. 297(5): E1056-E1066. doi:10.1152/ajpendo. 90908.2008. PMID:19724017.
2. Barnes, K., Ingram, J.C., Porras, O.H., Barros, L.F., Hudson, E.R., Fryer, L.G., et al. 2002. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115(11): 2433-2442. PMID:12006627.
3. Botker, H.E., Goodwin, G.W., Holden, J.E., Doenst, T., Gjedde, A., and Taegtmeyer, H. 1999. Myocardial glucose uptake measured with fluorodeoxyglucose: a proposed method to account for variable lumped constants. J. Nucl. Med. 40(7): 1186-1196. PMID:10405141.
4. Carroll, R., Carley, A.N., Dyck, J.R., and Severson, D.L. 2005. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am. J. Physiol. Endocrinol. Metab. 288(5): E900-E906. doi:10.1152/ajpendo. 00491.2004. PMID:15632103.
5. Chang, W., Zhang, M., Li, J., Meng, Z., Wei, S., Du, H., et al. 2013. Berberine improves insulin resistance in cardiomyocytes via activation of 5=-adenosine monophosphate-activated protein kinase. Metabolism, 62: 1159-1167. doi:10. 1016/j.metabol.2013.02.007. PMID:23537779.
6. Doenst, T., and Taegtmeyer, H. 1998. Complexities underlying the quantitative determination of myocardial glucose uptake with 2-deoxyglucose. J. Mol. Cell. Cardiol. 30(8): 1595-1604. doi:10.1006/jmcc.1998.0725. PMID:9737945.
7. Doenst, T., Holden, J.E., and Taegtmeyer, H. 1999. Limitations to the assessment of reperfusion injury with radiolabeled 2-deoxyglucose. Circulation, 99(12): 1646-1647. doi:10.1161/01.CIR.99.12.1646. PMID:10096945.
8. Dyck, J.R., and Lopaschuk, G.D. 2006. AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol. 574(1): 95-112. doi:10.1113/jphysiol. 2006.109389. PMID:16690706.
9. Folmes, C.D., Wagg, C.S., Shen, M., Clanachan, A.S., Tian, R., and Lopaschuk, G.D. 2009. Suppression of 5=-AMP-activated protein kinase activity does not impair recovery of contractile function during reperfusion of ischemic hearts. Am. J. Physiol. Heart Circ. Physiol. 297(1): H313-H321. doi:10.1152/ajpheart. 01298.2008. PMID:19429810.
10. Fujii, N., Jessen, N., and Goodyear, L.J. 2006. AMP-activated protein kinase and the regulation of glucose transport. Am. J. Physiol. Endocrinol. Metab. 291(5): E867-E877. doi:10.1152/ajpendo.00207.2006. PMID:16822958.
11. Furtado, L.M., Somwar, R., Sweeney, G., Niu, W., and Klip, A. 2002. Activation of the glucose transporter GLUT4 by insulin. Biochem. Cell Biol. 80(5): 569-578. doi:10.1139/o02-156. PMID:12440698.
12. Ganapathy, V., Thangaraju, M., and Prasad, P.D. 2009. Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 121(1): 29-40. doi:10.1016/j.pharmthera.2008.09.005. PMID:18992769.
13. Ginion, A., Auquier, J., Benton, C.R., Mouton, C., Vanoverschelde, J.L., Hue, L., et al. 2011. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Am. J. Physiol. Heart Circ. Physiol. 301(2): H469-H477. doi:10.1152/ajpheart.00986. 2010. PMID:21602475.
14. Gjedde, A. 1987. Does deoxyglucose uptake in the brain reflect energy metabolism? Biochem. Pharmacol. 36(12): 1853-1861. doi:10.1016/0006-2952(87) 90480-1. PMID:3297067.
15. Hardie, D.G., and Carling, D. 1997. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246(2): 259-273. doi:10.1111/j.1432-1033.1997.00259.x. PMID:9208914.
16. Hariharan, R., Bray, M., Ganim, R., Doenst, T., Goodwin, G.W., and Taegtmeyer, H. 1995. Fundamental limitations of [18F]2-deoxy-2-fluoro- D-glucose for assessing myocardial glucose uptake. Circulation, 91(9): 2435-2444. doi:10.1161/01.CIR.91.9.2435. PMID:7729031.
17. He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95(5): 2509-2514. doi:10.1073/pnas.95.5.2509. PMID:9482916.
18. Hood, R.D., Ranganathan, S., Jones, C.L., and Ranganathan, P.N. 1988. Teratogenic effects of a lipophilic cationic dye rhodamine 123, alone and in combination with 2-deoxyglucose. Drug Chem. Toxicol. 11(3): 261-274. doi:10.3109/01480548809017882. PMID:3181040.
19. Horman, S., Vertommen, D., Heath, R., Neumann, D., Mouton, V., Woods, A., et al. 2006. Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J. Biol. Chem. 281(9): 5335-5340. doi:10.1074/jbc. M506850200. PMID:16340011.
20. Jaswal, J.S., Gandhi, M., Finegan, B.A., Dyck, J.R., and Clanachan, A.S. 2006. Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5=-AMP-activated protein kinase. Am. J. Physiol. Heart Circ. Physiol. 291(4): H1883-H1892. doi:10.1152/ajpheart.01147.2005. PMID:16648181.
21. Kim, S.H., Shin, E.J., Kim, E.D., Bayaraa, T., Frost, S.C., and Hyun, C.K. 2007. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biol. Pharm. Bull. 30(11): 2120-2125. doi:10.1248/bpb.30.2120. PMID:17978486.
22. Kotani, K., Peroni, O.D., Minokoshi, Y., Boss, O., and Kahn, B.B. 2004. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J. Clin. Invest. 114(11): 1666-1675. doi:10.1172/ JCI200421341. PMID:15578099.
23. Kudo, N., Barr, A.J., Barr, R.L., Desai, S., and Lopaschuk, G.D. 1995. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5=-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270(29): 17513-17520. doi:10.1074/jbc.270.29.17513. PMID:7615556.
24. Kudo, N., Gillespie, J.G., Kung, L., Witters, L.A., Schulz, R., Clanachan, A.S., and Lopaschuk, G.D. 1996. Characterization of 5=AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim. Biophys. Acta, 1301(1-2): 67-75. PMID:8652652.
25. Li, J., Hu, X., Selvakumar, P., Russell, R.R., III, Cushman, S.W., Holman, G.D., and Young, L.H. 2004. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am. J. Physiol. Endocrinol. Metab. 287(5): E834-E841. doi:10.1152/ajpendo.00234.2004. PMID:15265762.
26. Li, J., Miller, E.J., Ninomiya-Tsuji, J., Russell, R.R., III, and Young, L.H. 2005. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ. Res. 97(9): 872-879. doi:10.1161/01.RES.0000187458.77026.10. PMID:16179588.
27. Mahajan, H., Richards, S.M., Rattigan, S., and Clark, M.G. 2004. Local methacholine but not bradykinin potentiates insulin-mediated glucose uptake in muscle in vivo by augmenting capillary recruitment. Diabetologia, 47(12): 2226-2234. doi:10.1007/s00125-004-1580-7. PMID:15602653.
28. Miller, E.J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., and Young, L.H. 2008. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature, 451(7178): 578-582. doi:10.1038/ nature06504. PMID:18235500.
29. Ong, L.C., Jin, Y., Song, I.C., Yu, S., Zhang, K., and Chow, P.K. 2008. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II. Acta Radiol. 49(10): 1145-1153. doi: 10.1080/02841850802482486. PMID:18979289.
30. Patel, N., Khayat, Z.A., Ruderman, N.B., and Klip, A. 2001. Dissociation of 5= AMP-activated protein kinase activation and glucose uptake stimulation by mitochondrial uncoupling and hyperosmolar stress: differential sensitivities to intracellular Ca2+ and protein kinase C inhibition. Biochem. Biophys. Res. Commun. 285(4): 1066-1070. doi:10.1006/bbrc.2001.5275. PMID:11467861.
31. Ruderman, N.B., Park, H., Kaushik, V.K., Dean, D., Constant, S., Prentki, M., and Saha, A.K. 2003. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol. Scand. 178(4): 435-442. doi:10.1046/j.1365-201X.2003.01164.x. PMID:12864749.
32. Russell, R.R., III, Li, J., Coven, D.L., Pypaert, M., Zechner, C., Palmeri, M., et al. 2004. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 114(4): 495-503. doi:10.1172/JCI19297. PMID:15314686.
33. Sajan, M.P., Standaert, M.L., Miura, A., Bandyopadhyay, G., Vollenweider, P., Franklin, D.M., et al. 2004. Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte- derived adipocytes and myotubes of obese subjects. J. Clin. Endocrinol. Metab. 89(8): 3994-3998. doi:10.1210/jc.2004-0106. PMID:15292339.
34. Sajan, M.P., Rivas, J., Li, P., Standaert, M.L., and Farese, R.V. 2006. Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport. J. Biol. Chem. 281(25): 17466-17473. doi:10.1074/jbc.M510803200. PMID:16644736.
35. Sambandam, N., and Lopaschuk, G.D. 2003. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog. Lipid Res. 42(3): 238-256. doi:10.1016/S0163-7827(02)00065-6. PMID: 12689619.
36. Sokoloff, L., Reivich, M., Kennedy, C., Des Rosiers, M.H., Patlak, C.S., Pettigrew, K.D., et al. 1977. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28(5): 897-916. doi:10.1111/j.1471-4159.1977.tb10649.x. PMID:864466.
37. Soltys, C.L., Kovacic, S., and Dyck, J.R. 2006. Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. Am. J. Physiol. Heart Circ. Physiol. 290(6): H2472-H2479. doi:10.1152/ajpheart.01206.2005. PMID:16428351.
38. Steinberg, G.R., and Kemp, B.E. 2009. AMPK in health and disease. Physiol. Rev. 89(3): 1025-1078. doi:10.1152/physrev.00011.2008. PMID:19584320.
39. Tanti, J.F., and Jager, J. 2009. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol. 9(6): 753-762. doi:10.1016/j.coph. 2009.07.004. PMID:19683471.
40. Ussher, J.R., and Lopaschuk, G.D. 2006. Clinical implications of energetic problems in cardiovascular disease. Heart and Metabolism, 32: 9-17.
41. Ussher, J.R., and Lopaschuk, G.D. 2008. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc. Res. 79(2): 259-268. doi:10.1093/cvr/cvn130. PMID:18499682.
42. Ussher, J.R., and Lopaschuk, G.D. 2009. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion. Basic Res. Cardiol. 104(2): 203-210. doi:10.1007/s00395-009-0003-9. PMID:19242641.
43. Ussher, J.R., Jaswal, J.S., Wagg, C.S., Armstrong, H.E., Lopaschuk, D.G., Keung, W., and Lopaschuk, G.D. 2009. Role of the atypical protein kinase Czeta in regulation of 5=-AMP-activated protein kinase in cardiac and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 297(2): E349-E357. doi:10.1152/ ajpendo.00009.2009. PMID:19625676.
44. Ussher, J.R., Folmes, C.D., Keung, W., Fillmore, N., Jaswal, J.S., Cadete, V.J., et al. 2012. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance. PLoS One, 7(5): e37703. doi:10.1371/journal.pone.0037703. PMID:22629445.
45. Warden, S.M., Richardson, C., O'Donnell, J., Jr., Stapleton, D., Kemp, B.E., and Witters, L.A. 2001. Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 354(2): 275-283. doi:10.1042/0264-6021:3540275. PMID: 11171104.
46. Wijesekara, N., Konrad, D., Eweida, M., Jefferies, C., Liadis, N., Giacca, A., et al. 2005. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25(3): 1135-1145. doi:10.1128/MCB.25.3.1135-1145.2005. PMID:15657439.
47. Yang, J., and Holman, G.D. 2006. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase- dependent reduction in GLUT4 endocytosis. Endocrinology, 147(6): 2728-2736. doi:10.1210/en.2005-1433. PMID:16513829.
48. Yu, B., Poirier, L.A., and Nagy, L.E. 1999. Mobilization of GLUT-4 from intracellular vesicles by insulin and K(+) depolarization in cultured H9c2 myotubes. Am. J. Physiol. 277(2): E259-E267. PMID:10444421.
49. Yu, B., Schroeder, A., and Nagy, L.E. 2000. Ethanol stimulates glucose uptake and translocation of GLUT-4 in H9c2 myotubes via a Ca(2+)-dependent mechanism. Am. J. Physiol. Endocrinol. Metab. 279(6): E1358-E1365. PMID:11093924.
50. Zarrinpashneh, E., Carjaval, K., Beauloye, C., Ginion, A., Mateo, P., Pouleur, A.C., et al. 2006. Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am. J. Physiol. Heart Circ. Physiol. 291(6): H2875-H2883. doi:10.1152/ajpheart.01032. 2005. PMID:16877552.